A Review of Leukemia in Children
DOI:
https://doi.org/10.22376/ijtos.2024.2.3.32-41Keywords:
Childhood leukemia, Pediatric cancers, Acute leukemia, Acute lymphoblastic leukemiaAbstract
Leukemia is the most common cancer in children, accounting for approximately one-third of all pediatric cancers. This disease affects the blood-forming tissues, with leukemic cells first growing in the bone marrow, then entering the peripheral blood, and possibly spreading to various organs, including the skin. Acute leukemia’s clinical symptoms stem from the frequently rapid onset of bone marrow failure. The clinical presentation typically includes high fever, gastrointestinal and pulmonary symptoms, severe and worsening anorexia, muscle and joint pain, and bleeding. This review explores the incidence and general epidemiology of childhood leukemia, including risk-increasing syndromes; recognizes the clinical presentation and interpretation of blood counts; examines potential oncologic emergencies; describes prognostic factors and the importance of minimal residual disease in precursor B-lymphoblastic leukemia; highlights supportive care in treating acute myelogenous leukemia; and addresses long-term complications of modern childhood leukemia treatments. This narrative review discusses the evidence suggesting an in-utero origin of childhood acute leukemia, focusing on acute lymphoblastic leukemia (ALL) and acute myeloid leukemia (AML). It highlights the significant diagnostic presence of these acute leukemias among hematologic cancers, the investigations into prenatal leukemogenesis, and the literature on prenatal risk factors during gestation.
References
El-Zine MA, Alhadi AM, Ishak AA, Al-Shamahy HA. Prevalence of different types of leukemia and associated factors among children with leukemia in children’s cancer units at Al-Kuwait Hospital, Sana’a City: A cross-sectional study. Glob. J. Ped. Neonatol. Car. 2021;3:000569.
Bhatnagar S, Chandra J, Narayanb S. Hematological changes and predictors of bone marrow recovery in patients with neutropenic episodes in acute lymphoblastic leukemia. Journal of tropical pediatrics. 2002 Aug 1;48(4):200-3.
Arber DA, Carter NH, Ikle D, Slovak ML. Value of combined morphologic, cytochemical, and immunophenotypic features in predicting recurrent cytogenetic abnormalities in acute myeloid leukemia. Human pathology. 2003 May 1;34(5):479-83.
Matsuo T, Tomonaga M, Bennett JM, Kuriyama K, Imanaka F, Kuramoto A, Kamada N, Ichimaru M, Finch SC, Pisciotta AV, Ishimaru T. Reclassification of leukemia among A-bomb survivers in Nagasaki using French-American-British (FAB) classification for acute leukemia. Japanese journal of clinical oncology. 1988 Jun 1;18(2):91-6.
Langabeer SE, Gale RE, Rollinson SJ, Morgan GJ, Linch DC. Mutations of the AML1 gene in acute myeloid leukemia of FAB types M0 and M7. Genes, Chromosomes and Cancer. 2002 May;34(1):24-32.
Koga M, Furukawa S. Leukemia cutis in three children: clinical and immunohistochemical studies. Pediatric dermatology. 1996 May;13(3):200-6.
Ma SK, Wan TS, Chan LC. Cytogenetics and molecular genetics of childhood leukemia. Hematological Oncology. 1999 Sep;17(3):91-105.
Shahverdi E, Shahriari M, Zare S, Rahiminejad MS, Soleimani FH, Maki M, Manouchehri R, Abdo MH. Common presenting signs and symptoms in children with acute lymphoblastic leukemia. Basic & Clinical Cancer Research. 2020 Aug 13;12(1):26-33.
Auletta JJ, O'Riordan MA, Nieder ML. Infections in children with cancer: a continued need for the comprehensive physical examination. Journal of pediatric hematology/oncology. 1999 Nov 1;21(6):501-8.
Tattoli L, Leonardi S, Carabellese F, Solarino B. Acute lymphoblastic leukemia misdiagnosed as lethal child neglect. Rom J Leg Med. 2012;20:111-6.
Talbot GH, Provencher M, Cassileth PA. Persistent fever after recovery from granulocytopenia in acute leukemia. Archives of internal medicine. 1988 Jan 1;148(1):129-35.
Pui CH, Cheng C, Leung W, Rai SN, Rivera GK, Sandlund JT, Ribeiro RC, Relling MV, Kun LE, Evans WE, Hudson MM. Extended follow-up of long-term survivors of childhood acute lymphoblastic leukemia. New England Journal of Medicine. 2003 Aug 14;349(7):640-9.
Savage SA, Dufour C. Classical inherited bone marrow failure syndromes with high risk for myelodysplastic syndrome and acute myelogenous leukemia. InSeminars in hematology 2017 Apr 1 (Vol. 54, No. 2, pp. 105-114). WB Saunders.
Pamuk GE, Taşçi M, Öztürk E, Demir M. Successful treatment of severe gastrointestinal bleeding after chemotherapy in acute myeloblastic leukemia with recombinant activated factor VII: report on one case and review of other uses in acute leukemias. Medical Oncology. 2010 Mar;27:16-9.
Ojala AE, Lanning FP, Lanning BM. Abdominal ultrasound findings during and after treatment of childhood acute lymphoblastic leukemia. Medical and Pediatric Oncology: The Official Journal of SIOP—International Society of Pediatric Oncology (Societé Internationale d'Oncologie Pédiatrique. 1997 Oct;29(4):266-71.
Bittencourt AL, Barbosa HS, Vieira MD, Farré L. Adult T-cell leukemia/lymphoma (ATL) presenting in the skin: clinical, histological and immunohistochemical features of 52 cases. Acta Oncologica. 2009 Jan 1;48(4):598-604.
Abreu Velez AM, Howard MS. Diagnosis and treatment of cutaneous paraneoplastic disorders. Dermatologic Therapy. 2010 Nov;23(6):662-75.
Ivy SP, Mackall CL, Gore L, Gress RE, Hartley AH. Demodicidosis in childhood acute lymphoblastic leukemia: an opportunistic infection occurring with immunosuppression. The Journal of pediatrics. 1995 Nov 1;127(5):751-4.
Buchanan GR, Adix L. Grading of hemorrhage in children with idiopathic thrombocytopenic purpura. The Journal of pediatrics. 2002 Nov 1;141(5):683-8.
Abreu Velez AM, Howard MS. Diagnosis and treatment of cutaneous paraneoplastic disorders. Dermatologic Therapy. 2010 Nov;23(6):662-75.
Karalis A, Tischkowitz M, Millington GW. Dermatological manifestations of inherited cancer syndromes in children. British Journal of Dermatology. 2011 Feb 1;164(2):245-56.
Berger T, Sherman S, Hayman L, Wolach O, Shacham-Abulafia A, Raanani P, Pasvolsky O. Skin biopsies in acute myeloid leukemia patients undergoing intensive chemotherapy are safe and effect patient management. Scientific reports. 2021 Jun 7;11(1):11940.
Harvey RC, Tasian SK. Clinical diagnostics and treatment strategies for Philadelphia chromosome–like acute lymphoblastic leukemia. Blood advances. 2020 Jan 14;4(1):218-28.
Exelby PR, Ghandchi A, Lansigan N, Schwartz I. Management of the acute abdomen in children with leukemia. Cancer. 1975 Mar;35(3):826-9.
Karimi M, Mehrabani D, Yarmohammadi H, Jahromi FS. The prevalence of signs and symptoms of childhood leukemia and lymphoma in Fars Province, Southern Iran. Cancer detection and prevention. 2008 Jan 1;32(2):178-83.
Imashuku S, Hibi S, Bessho F, Tsuchida M, Nakahata T, Miyazaki S, Tsukimoto I, Hamajima N, Pediatric AA Follow-up Study Group in Japan. Detection of myelodysplastic syndrome/acute myeloid leukemia evolving from aplastic anemia in children, treated with recombinant human G-CSF. Haematologica. 2003 Jan 1;88(11):ECR31-.
Aisner M, Hoxie TB. Bone and joint pain in leukemia, simulating acute rheumatic fever and subacute bacterial endocarditis. New England Journal of Medicine. 1948 May 20;238(21):733-7.
Hossain MJ, Xie L, McCahan SM. Characterization of pediatric acute lymphoblastic leukemia survival patterns by age at diagnosis. Journal of cancer epidemiology. 2014;2014(1):865979.
Kızılocak H, Okcu F. Late effects of therapy in childhood acute lymphoblastic leukemia survivors. Turkish Journal of Hematology. 2019 Mar;36(1):1.
Greaves MF, Hariri G, Newman RA, Sutherland DR, Ritter MA, Ritz J. Selective expression of the common acute lymphoblastic leukemia (gp 100) antigen on immature lymphoid cells and their malignant counterparts.
Oeffinger KC, Hudson MM. Long‐term complications following childhood and adolescent cancer: foundations for providing risk‐based health care for survivors. CA: a cancer journal for clinicians. 2004 Jul;54(4):208-36.
Howard SC, Pui CH. Endocrine complications in pediatric patients with acute lymphoblastic leukemia. Blood reviews. 2002 Dec 1;16(4):225-43.
Kızılocak H, Okcu F. Late effects of therapy in childhood acute lymphoblastic leukemia survivors. Turkish Journal of Hematology. 2019 Mar;36(1):1.
Menon NM, Katsanis E, Khalpey Z, Whitlow P. Pediatric secondary chronic myeloid leukemia following cardiac transplantation for anthracycline‐induced cardiomyopathy. Pediatric Blood & Cancer. 2015 Jan;62(1):166-8.
Borrescio-Higa F, Valdés N. The psychosocial burden of families with childhood blood cancer. International journal of environmental research and public health. 2022 Jan 5;19(1):599.
Demidowicz E, Pogorzała M, Łęcka M, Żołnowska H, Marjańska A, Kubicka M, Kuryło-Rafińska B, Czyżewski K, Dębski R, Kołtan A, Richert-Przygońska M. Outcome of pediatric acute lymphoblastic leukemia: sixty years of progress. Anticancer Research. 2019 Sep 1;39(9):5203-7.
Carlson CA, Hobbie WL, Brogna M, Ginsberg JP. A multidisciplinary model of care for childhood cancer survivors with complex medical needs. Journal of Pediatric Oncology Nursing. 2008 Jan;25(1):7-13.
Pannier ST, Mann K, Warner EL, Rosen S, Acharya A, Hacking C, Gerdy C, Wright J, Wu YP, Kirchhoff AC. Survivorship care plan experiences among childhood acute lymphoblastic leukemia patients and their families. BMC pediatrics. 2019 Dec;19:1-9.
Sekeres MA, Guyatt G, Abel G, Alibhai S, Altman JK, Buckstein R, Choe H, Desai P, Erba H, Hourigan CS, LeBlanc TW. American Society of Hematology 2020 guidelines for treating newly diagnosed acute myeloid leukemia in older adults. Blood advances. 2020 Aug 11;4(15):3528-49.
Vaughn JE, Othus M, Powell MA, Gardner KM, Rizzuto DL, Hendrie PC, Becker PS, Pottinger PS, Estey EH, Walter RB. Resource utilization and safety of outpatient management following intensive induction or salvage chemotherapy for acute myeloid leukemia or myelodysplastic syndrome: a nonrandomized clinical comparative analysis. JAMA oncology. 2015 Nov 1;1(8):1120-7.
Getz KD, Szymczak JE, Li Y, Madding R, Huang YS, Aftandilian C, Arnold SD, Bona KO, Caywood E, Collier AB, Gramatges MM. Medical outcomes, quality of life, and family perceptions for outpatient vs inpatient neutropenia management after chemotherapy for pediatric acute myeloid leukemia. JAMA network open. 2021 Oct 1;4(10):e2128385-.
Campana D. Minimal residual disease in acute lymphoblastic leukemia. Hematology 2010, the American Society of Hematology Education Program Book. 2010 Dec 4;2010(1):7-12.
Neale GA, Coustan-Smith E, Stow P, Pan Q, Chen X, Pui CH, Campana D. Comparative analysis of flow cytometry and polymerase chain reaction for the detection of minimal residual disease in childhood acute lymphoblastic leukemia. Leukemia. 2004 May;18(5):934-8.
Loh ML, DelRocco N, Borowitz MJ, Rabin KR, Zweidler-McKay PA, Maloney KW, Mattano LA, Larsen EC, Angiolillo AL, Schore RJ, Burke MJ. Enhanced risk stratification of 21,178 children, adolescents, and young adults with acute lymphoblastic leukemia (ALL) incorporating white blood count (WBC), age, and minimal residual disease (MRD) at day 8 and 29 as continuous variables: a Children's Oncology Group (COG) report. Blood. 2020 Nov 5;136:39-40.
Mahmoud HH, Rivera GK, Hancock ML, Krance RA, Kun LE, Behm FG, Ribeiro RC, Sandlund JT, Crist WM, Pui CH. Low leukocyte counts with blast cells in cerebrospinal fluid of children with newly diagnosed acute lymphoblastic leukemia. New England Journal of Medicine. 1993 Jul 29;329(5):314-9.
Rowe JM, Lichtman MA. Hyperleukocytosis and leukostasis: common features of childhood chronic myelogenous leukemia.
Razis E, Arlin ZA, Ahmed T, Feldman EJ, Puccio C, Cook P, Chun HG, Helson L, Mittelman A. Incidence and treatment of tumor lysis syndrome in patients with acute leukemia. Acta haematologica. 1994 Feb 18;91(4):171-4.
Zarnegar-Lumley S, Caldwell KJ, Rubnitz JE. Relapsed acute myeloid leukemia in children and adolescents: current treatment options and future strategies. Leukemia. 2022 Aug;36(8):1951-60.
Mabrey FL, Gardner KM, Shannon Dorcy K, Perdue A, Smith HA, Davis AM, Hammer C, Rizzuto D, Jones S, Quach K, Scott BL. Outpatient intensive induction chemotherapy for acute myeloid leukemia and high-risk myelodysplastic syndrome. Blood advances. 2020 Feb 25;4(4):611-6.
Paudel A, Dhital R, Areoye G, Basnet S, Tachamo N. Sweet’s syndrome in a granulocytopenic patient with acute myeloid leukemia on FLT3 inhibitor. Journal of Community Hospital Internal Medicine Perspectives. 2020 May 3;10(3):275-8.
Potashner R, Weinblatt ME, Glasser CL. Outpatient supportive care for pediatric acute myeloid leukemia: A single institution’s experience. Pediatric Hematology and Oncology. 2021 Nov 17;38(8):722-30.
Campana D. Minimal residual disease in acute lymphoblastic leukemia. Hematology 2010, the American Society of Hematology Education Program Book. 2010 Dec 4;2010(1):7-12.
Theunissen P, Mejstrikova E, Sedek L, van der Sluijs-Gelling AJ, Gaipa G, Bartels M, Sobral da Costa E, Kotrova M, Novakova M, Sonneveld E, Buracchi C. Standardized flow cytometry for highly sensitive MRD measurements in B-cell acute lymphoblastic leukemia. Blood, The Journal of the American Society of Hematology. 2017 Jan 19;129(3):347-57.
Theodorou I, Delfau-Larue MH, Bigorgne C, Lahet C, Cochet G, Bagot M, Wechsler J, Farcet JP. Cutaneous T-cell infiltrates: analysis of T-cell receptor gamma gene rearrangement by polymerase chain reaction and denaturing gradient gel electrophoresis.
Pui CH, Crist WM. High risk lymphoblastic leukemia in children: prognostic factors and management. Blood Reviews. 1987 Mar 1;1(1):25-33.
Rocha JM, Xavier SG, Souza ME, Murao M, de Oliveira BM. Comparison between flow cytometry and standard PCR in the evaluation of MRD in children with acute lymphoblastic leukemia treated with the GBTLI LLA–2009 protocol. Pediatric hematology and oncology. 2019 Jul 4;36(5):287-301.
Cheng SH, Lau KM, Li CK, Chan NP, Ip RK, Cheng CK, Lee V, Shing MM, Leung AW, Ha SY, Cheuk DK. Minimal residual disease-based risk stratification in Chinese childhood acute lymphoblastic leukemia by flow cytometry and plasma DNA quantitative polymerase chain reaction. PLoS One. 2013 Jul 25;8(7):e69467.
Vrooman LM, Silverman LB. Treatment of childhood acute lymphoblastic leukemia: prognostic factors and clinical advances. Current hematologic malignancy reports. 2016 Oct;11:385-94.
Eckert C, Hagedorn N, Sramkova L, Mann G, Panzer-Grümayer R, Peters C, Bourquin JP, Klingebiel T, Borkhardt A, Cario G, Alten J. Monitoring minimal residual disease in children with high-risk relapses of acute lymphoblastic leukemia: prognostic relevance of early and late assessment. Leukemia. 2015 Aug;29(8):1648-55.
Salzer WL, Jones TL, Devidas M, Dreyer ZE, Gore L, Winick NJ, Sung L, Raetz E, Loh ML, Wang CY, De Lorenzo P. Decreased induction morbidity and mortality following modification to induction therapy in infants with acute lymphoblastic leukemia enrolled on AALL0631: a report from the Children's Oncology Group. Pediatric blood & cancer. 2015 Mar;62(3):414-8.
Ventura GJ, Hester JP, Smith TL, Keating MJ. Acute myeloblastic leukemia with hyperleukocytosis: risk factors for early mortality in induction. American journal of hematology. 1988 Jan;27(1):34-7.
Montesinos P, Lorenzo I, Martín G, Sanz J, Pérez-Sirvent ML, Martínez D, Ortí G, Algarra L, Martínez J, Moscardó F, de la Rubia J. Tumor lysis syndrome in patients with acute myeloid leukemia: identification of risk factors and development of a predictive model. Haematologica. 2008 Jan 1;93(1):67-74.
Ueda T, Kita K, Kagawa D, Tamori S, Ando S, Sasada M, Yoshida Y, Uchino H, Nakamura T. Acute leukemia with two cell populations of lymphoblasts and monoblasts. Leukemia research. 1984 Jan 1;8(1):63-9.
Myers TJ, Cole SR, Klatsky AU, Hild DH. Respiratory failure due to pulmonary leukostasis following chemotherapy of acute nonlymphocytic leukemia. Cancer. 1983 May 15;51(10):1808-13.
Pirker R, Hedenus M, Vansteenkiste J, Hernandez E, Belton L, Terwey JH. Effectiveness of darbepoetin alfa for chemotherapy-induced anemia when initiated at hemoglobin≤ 10 g/dL. Clinical Therapeutics. 2016 Jan 1;38(1):122-35.
Reikvam H, Olsnes Kittang A, Melve G, Anders Mosevoll K, Tore Bentsen P, Ersvaer E, Tore Gjertsen B, Bruserud O. Targeted anti-leukemic therapy as disease-stabilizing treatment for acute myeloid leukemia relapse after allogeneic stem cell transplantation: Will it be possible to combine these strategies with retransplantation or donor lymphocyte infusions?. Current cancer drug targets. 2013 Jan 1;13(1):30-47.
Gopakumar KG, Seetharam S, Km JK, Nair M, Rajeswari B, Cs G, Vr P, Thankamony P. Risk‐based management strategy and outcomes of tumor lysis syndrome in children with leukemia/lymphoma: Analysis from a resource‐limited setting. Pediatric Blood & Cancer. 2018 Dec;65(12):e27401.
Nee LH, Mashor MY, Hassan R. White blood cell segmentation for acute leukemia bone marrow images. Journal of Medical Imaging and Health Informatics. 2012 Sep 1;2(3):278-84.
Daniele S, Giacomelli C, Martini C. Brain ageing and neurodegenerative disease: The role of cellular waste management. Biochemical pharmacology. 2018 Dec 1;158:207-16.
Perazella MA, Eisen RN, Frederick WG, Brown E. Renal failure and severe hypokalemia associated with acute myelomonocytic leukemia. American journal of kidney diseases. 1993 Sep 1;22(3):462-7.
Lahoti A, Kantarjian H, Salahudeen AK, Ravandi F, Cortes JE, Faderl S, O'Brien S, Wierda W, Mattiuzzi GN. Predictors and outcome of acute kidney injury in patients with acute myelogenous leukemia or high‐risk myelodysplastic syndrome. Cancer. 2010 Sep 1;116(17):4063-8.
Montesinos P, Lorenzo I, Martín G, Sanz J, Pérez-Sirvent ML, Martínez D, Ortí G, Algarra L, Martínez J, Moscardó F, de la Rubia J. Tumor lysis syndrome in patients with acute myeloid leukemia: identification of risk factors and development of a predictive model. Haematologica. 2008 Jan 1;93(1):67-74.
Ozdemir MA, Karakukcu M, Patiroglu T, Torun YA, Kose M. Management of hyperleukocytosis and prevention of tumor lysis syndrome with low-dose prednisone continuous infusion in children with acute lymphoblastic leukemia. Acta Haematologica. 2009 Apr 2;121(1):56-62.
O'Regan S, Carson S, Chesney RW, Drummond KN. Electrolyte and acid-base disturbances in the management of leukemia.
Gopakumar KG, Seetharam S, Km JK, Nair M, Rajeswari B, Cs G, Vr P, Thankamony P. Risk‐based management strategy and outcomes of tumor lysis syndrome in children with leukemia/lymphoma: Analysis from a resource‐limited setting. Pediatric Blood & Cancer. 2018 Dec;65(12):e27401.
Silic-Benussi M, Sharova E, Ciccarese F, Cavallari I, Raimondi V, Urso L, Corradin A, Kotler H, Scattolin G, Buldini B, Francescato S. mTOR inhibition downregulates glucose-6-phosphate dehydrogenase and induces ROS-dependent death in T-cell acute lymphoblastic leukemia cells. Redox biology. 2022 May 1;51:102268.
Soares M, Feres GA, Salluh JI. Systemic inflammatory response syndrome and multiple organ dysfunction in patients with acute tumor lysis syndrome. Clinics. 2009;64:479-81.
Della Rocca AM, Leonart LP, Ferreira VL, Tonin FS, Steffenello-Durigon G, Del Moral JA, Fernandez-Llimos F, Pontarolo R. Chemotherapy treatments for Burkitt lymphoma: Systematic review of interventional studies. Clinical Lymphoma Myeloma and Leukemia. 2021 Aug 1;21(8):514-25.
Kornberg A, Polliack A. Serum lactic dehydrogenase (LDH) levels in acute leukemia: marked elevations in lymphoblastic leukemia. Blood. 1980 Sep 1;56(3):351-5.
McNabb RA, McNabb FA. Physiological chemistry of uric acid: solubility, colloid and ion-binding properties. Comparative Biochemistry and Physiology Part A: Physiology. 1980 Jan 1;67(1):27-34.
Schnackenberg CG, Wilkins FC, Granger JP. Role of nitric oxide in modulating the vasoconstrictor actions of angiotensin II in preglomerular and postglomerular vessels in dogs. Hypertension. 1995 Dec;26(6):1024-9.
Ghezelbash S, Khosravi M. Acupressure for nausea-vomiting and fatigue management in acute lymphoblastic leukemia children. Journal of Nursing and Midwifery Sciences. 2017 Sep 30;4(3):75-81.
Truong TH, Beyene J, Hitzler J, Abla O, Maloney AM, Weitzman S, Sung L. Features at presentation predict children with acute lymphoblastic leukemia at low risk for tumor lysis syndrome. Cancer. 2007 Oct 15;110(8):1832-9.
Hoffman R, Kopel S, Hsu SD, Dainiak N, Zanjani ED. T cell chronic lymphocytic leukemia: presence in bone marrow and peripheral blood of cells that suppress erythropoiesis in vitro.
Joshi MD, Karode AH, Suralkar SR. White blood cells segmentation and classification to detect acute leukemia. International Journal of Emerging Trends & Technology in Computer Science (IJETTCS). 2013 Jun;2(3):147-51.
Majumder D, Banerjee D, Chandra S, Banerjee S, Chakrabarti A. Red cell morphology in leukemia, hypoplastic anemia and myelodysplastic syndrome. Pathophysiology. 2006 Dec 1;13(4):217-25.
Shanbhag SP, Roy CN. Anemia of Chronic Inflammation. Anemia. 2018 May 3:150.
Price JF. Congestive heart failure in children. Pediatrics in Review. 2019 Feb 1;40(2):60-70..
Karon BS, Van Buskirk CM, Jaben EA, Hoyer JD, Thomas DD. Temporal sequence of major biochemical events during blood bank storage of packed red blood cells. Blood Transfusion. 2012 Oct;10(4):453.
Lazuwardi RA, Andarsini MR, Hernaningsih Y. Clinical and laboratory effects of exchange transfusion in pediatric acute lymphoblastic leukemia with hyperleukocytosis. Paediatrica Indonesiana. 2023 Nov 27;63(6):464-71.
Haase R, Merkel N, Diwan O, Elsner K, Kramm CM. Leukapheresis and exchange transfusion in children with acute leukemia and hyperleukocytosis. A single center experience. Klinische Paediatrie. 2009 Nov;221(06):374-8.
Wang Y, Gao A, Zhao H, Lu P, Cheng H, Dong F, Gong Y, Ma S, Zheng Y, Zhang H, Zhang Y. Leukemia cell infiltration causes defective erythropoiesis partially through MIP-1α/CCL3. Leukemia. 2016 Sep;30(9):1897-908.
Stuber ML, Christakis DA, Houskamp B, Kazak AE. Posttrauma symptoms in childhood leukemia survivors and their parents. Psychosomatics. 1996 May 1;37(3):254-61.
Rowland JM. Molecular genetic diagnosis of pediatric cancer: current and emerging methods. Pediatric Clinics. 2002 Dec 1;49(6):1415-35.
Kruse A, Abdel-Azim N, Kim HN, Ruan Y, Phan V, Ogana H, Wang W, Lee R, Gang EJ, Khazal S, Kim YM. Minimal residual disease detection in acute lymphoblastic leukemia. International journal of molecular sciences. 2020 Feb 5;21(3):1054.
Ravindranath Y, Kaplan J, Zuelzer WW. Significance of mediastinal mass in acute lymphoblastic leukemia. Pediatrics. 1975 Jun 1;55(6):889-93.
Sanz MA, Montesinos P. Open issues on bleeding and thrombosis in acute promyelocytic leukemia. Thrombosis research. 2010 Apr 1;125:S51-4.
Clark JJ, Berman JN, Look AT. Myeloid leukemia, myelodysplasia, and myeloproliferative disease in children. Oncology of infancy and childhood. 1st ed. Philadelphia: Saunders Elsevier. 2009 Jan 1:331-402.
Pabón-Rivera S, Flores RR, Frei-Jones M. The Complete Blood Count: A Practical Tool for the Pediatrician. Pediatrics in Review. 2023 Jul 1;44(7):363-82.
Wagner G, Fenchel K, Back W, Schulz A, Sachse MM. Leukemia cutis–epidemiology, clinical presentation, and differential diagnoses. JDDG: Journal der Deutschen Dermatologischen Gesellschaft. 2012 Jan;10(1):27-36.
Shahriari M, Shakibazad N, Haghpanah S, Ghasemi K. Extramedullary manifestations in acute lymphoblastic leukemia in children: a systematic review and guideline-based approach of treatment. American Journal of Blood Research. 2020;10(6):360.
Hamid GA. Acute leukemia clinical presentation. Leukemia. 2013 May 15;75.
Rawat J, Singh A, Bhadauria HS, Virmani J, Devgun JS. Classification of acute lymphoblastic leukaemia using hybrid hierarchical classifiers. Multimedia Tools and Applications. 2017 Sep;76(18):19057-85.
Kaddu S, Smolle J, Cerroni L, Kerl H. Prognostic evaluation of specific cutaneous infiltrates in B‐chronic lymphocytic leukemia. Journal of cutaneous pathology. 1996 Dec;23(6):487-94.
Habeshian KA, Cohen BA. Nodules and tumors. Pediatric Dermatology E-Book. 2021 Jan 1:133.
Hogan SF, Osborne BM, Butler JJ. Unexpected splenic nodules in leukemic patients. Human pathology. 1989 Jan 1;20(1):62-8.
Hallek M. Chronic lymphocytic leukemia: 2020 update on diagnosis, risk stratification and treatment. American journal of hematology. 2019 Nov;94(11):1266-87.
Kato M. MRD in Pediatric ALL. Pediatric Acute Lymphoblastic Leukemia. 2020:37-43.
DeAngelo DJ. The use of novel monoclonal antibodies in the treatment of acute lymphoblastic leukemia. Hematology 2014, the American Society of Hematology Education Program Book. 2015 Dec 5;2015(1):400-5.
Sutton R, Shaw PJ, Venn NC, Law T, Dissanayake A, Kilo T, Haber M, Norris MD, Fraser C, Alvaro F, Revesz T. Persistent MRD before and after allogeneic BMT predicts relapse in children with acute lymphoblastic leukaemia. British Journal of Haematology. 2015 Feb;168(3):395-404.
Dworzak MN, Fröschl G, Printz D, Mann G, Pötschger U, Mühlegger N, Fritsch G, Gadner H. Prognostic significance and modalities of flow cytometric minimal residual disease detection in childhood acute lymphoblastic leukemia. Blood, The Journal of the American Society of Hematology. 2002 Mar 15;99(6):1952-8.
Basso G, Buldini B, De Zen L, Orfao A. New methodologic approaches for immunophenotyping acute leukemias. haematologica. 2001 Jan 1;86(7):675-92.
Published
How to Cite
Issue
Section
Copyright (c) 2024 Somenath Ghosh, Sanjeev Kumar Jha, Amit Kumar Choudhary, Akriti yadav
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.